Glyoxalase 1 loss reduces fatty liver but impairs glucose handling in male mice
Physiological Reports · 2026
DOI: 10.14814/phy2.71106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2026. Verfasst von Emely A Hoffman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Lactoylglutathione Lyase, Fatty Liver, Blood Glucose, Glucose. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, HHS | National Institutes of Health (NIH), NIDDK NIH HHS.
Abstract (Originalsprache)
We demonstrate the generation and characterization of the methylglyoxal detoxifying enzyme, glyoxalase 1, knockout mice ( Glo1 −/− ). With a 16‐week high‐fat high sucrose (HFHS) diet, Glo1 −/− mice had a significant reduction of hepatic lipid accumulation when compared to WT counterparts. Paradoxically, these effects are limited to the liver, as no significant impact on white adipose tissue was observed. We also show that Glo1 −/− mice have a significant worsening of glycemic control, showing a significant increase in fasting blood glucose and oral glucose tolerance. Although previous findings have suggested a role for GLO1 in kidney health, our results show no overt kidney phenotype resulting from Glo1 loss. Collectively, these results demonstrate a role for GLO1 in hepatic lipid metabolism while having a minimal impact on adipose or kidney function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
- Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Pharmaceutical Sciences, the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Aging & Cardiovascular Discovery Center, Department of Cardiovascular Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
- Division of Endocrinology, Department of Medicine, College of Medicine, University of Arizona, Tucson, Arizona, USA.
ORCID-Profile: James J Galligan
Förderung
- NIAAA NIH HHS
- HHS | National Institutes of Health (NIH)
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
Zitieren
APA
Hoffman, E. A., Phoebe, A. M., Trujillo, M. N., Zhang, W. C., Jennings, E. Q., Farrera, D. O., Orlicky, D. J., Rutt, L. N., McCullough, R. L., Huacachino, A. A., Marcinkiewicz, M. M., Snyder, N. W., Bruner, K. R., Payan, K. B., Martinez, D. J. F., Stern, J. H., & Galligan, J. J. (2026). Glyoxalase 1 loss reduces fatty liver but impairs glucose handling in male mice. Physiological Reports. https://doi.org/10.14814/phy2.71106
Vancouver
Hoffman EA, Phoebe AM, Trujillo MN, Zhang WC, Jennings EQ, Farrera DO, et al. Glyoxalase 1 loss reduces fatty liver but impairs glucose handling in male mice. Physiological Reports. 2026. doi:10.14814/phy2.71106
BibTeX
@article{Hoffman2026,
author = {Hoffman, Emely A and Phoebe, Aiden M and Trujillo, Marissa N and Zhang, Wei Chen and Jennings, Erin Q and Farrera, Dominique O and Orlicky, David J and Rutt, Lauren N and McCullough, Rebecca L and Huacachino, Andrea A and Marcinkiewicz, Mariola M and Snyder, Nathaniel W and Bruner, Kassandra R and Payan, Kimberly Bassoco and Martinez, Diego Juan Federico and Stern, Jennifer H and Galligan, James J},
title = {Glyoxalase 1 loss reduces fatty liver but impairs glucose handling in male mice},
journal = {Physiological Reports},
year = {2026},
doi = {10.14814/phy2.71106}
}
EUVIMED